Artificial intelligence-based cardiovascular/stroke risk stratification in women affected by autoimmune disorders: a

Ekta Tiwari1, Dipti Shrimankar1, Mahesh Maindarkar2,3

  • 1Vishvswarya National Institute of Technology, Nagpur, India.

PubMed

Insights

Women with autoimmune diseases (AD) face underestimated cardiovascular disease (CVD) and stroke risks. Artificial intelligence models integrating biomarkers and carotid ultrasound improve risk prediction, aiding timely interventions.

Area of Science:

  • Cardiovascular disease research
  • Autoimmune disease management
  • Medical artificial intelligence

Background:

  • Women with chronic autoimmune diseases (AD) experience disproportionately high cardiovascular disease (CVD) and stroke risks, often underestimated by traditional assessments.
  • Vitamin D deficiency is linked to increased susceptibility to AD and associated cardiovascular complications.
  • Current CVD risk stratification in AD lacks precision, necessitating advanced methods for accurate assessment.

Purpose of the Study:

  • To investigate the relationship between AD and CVD/stroke markers, including autoantibody-influenced plaque burden.
  • To identify surrogate biomarkers for coronary artery disease (CAD) using radiomics features like carotid intima-media thickness (cIMT) and plaque area (PA).
  • To develop and validate automated CVD/stroke risk identification models using machine learning (ML) and deep learning (DL) in women with AD.

Main Methods:

  • Analysis of biomarker data from women with AD, encompassing carotid ultrasonography, clinical parameters, autoantibody profiles, and vitamin D levels.
  • Development of artificial intelligence (AI) models to integrate diverse data for precise CVD/stroke risk prediction.
  • Utilizing radiomics features (cIMT, PA) and autoantibody levels (RF, ACPAs) within AI frameworks.

Main Results:

  • A significant association was found between AD duration and elevated cIMT/PA, indicating increased CVD risk.
  • Higher levels of rheumatoid factor (RF) and anti-citrullinated peptide antibodies (ACPAs) correlated with heightened CVD risk.
  • AI models demonstrated superior performance over conventional methods by effectively integrating imaging data and AD-specific factors.

Conclusions:

  • AI-driven risk stratification shows promise for improving cardiovascular outcomes in women with chronic autoimmune diseases.
  • Interdisciplinary collaboration is essential for comprehensive management of CVD/stroke risks in this patient population.
  • AI-assisted risk assessment can enhance treatment decisions and patient management strategies.